#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16150	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2057	780.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	1003	C,A	935,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16150	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2057	780.1	0	HET	.	.	.	C519T	.	519	519	C	746	746	C	904	C,T	655,182	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29450	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3452	850.0	0	.	n	.	0	T695C	SNP	695	695	T	976	976	C	929	C	863	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29450	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3452	850.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1618	1618	A	982	A,G	922,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29450	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3452	850.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2252	2252	C	1028	C,T	943,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29450	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3452	850.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2878	2878	T	875	T,C	825,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29450	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3452	850.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2326	2326	A	980	A	925	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29450	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3452	850.0	0	HET	.	.	.	G540A	.	540	540	G	821	821	G	991	G,A	698,215	.	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2234	folP	852	852	100.0	folP.l15.c30.ctg.1	1295	170.3	1	SNP	p	R228S	1	.	.	682	684	AGC	901	903	AGC	237;239;238	A;G;C	214;217;215	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5916	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3489	169.2	1	SNP	p	S91F	0	.	.	271	273	TCC	629	631	TCC	212;208;211	T;C;C	190;190;190	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5916	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3489	169.2	1	SNP	p	D95G	0	.	.	283	285	GAC	641	643	GAC	212;209;207	G;A;C	194;190;189	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5916	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3489	169.2	1	SNP	p	D95N	0	.	.	283	285	GAC	641	643	GAC	212;209;207	G;A;C	194;190;189	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1740	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1319	131.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	410	412	ACC	220;219;219	A;C;C	199;200;200	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1740	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1319	131.6	0	.	p	.	0	R44H	NONSYN	130	132	CGC	425	427	CAC	217;220;221	C;A;C	194;192;197	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1740	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1319	131.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	608	610	CAC	237;239;239	C;A;C	219;221;221	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1740	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1319	131.6	1	SNP	p	G45D	0	.	.	133	135	GGC	428	430	GGC	223;226;227	G;G;C	199;201;201	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	968	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	927	103.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	193.8	1	SNP	p	D86N	0	.	.	256	258	GAC	550	552	GAC	239;239;242	G;A;C	225;223;228	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	193.8	1	SNP	p	S87W	0	.	.	259	261	AGT	553	555	AGT	245;245;242	A;G;T	229;229;226	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	193.8	1	SNP	p	S87I	0	.	.	259	261	AGT	553	555	AGT	245;245;242	A;G;T	229;229;226	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	193.8	1	SNP	p	S87R	0	.	.	259	261	AGT	553	555	AGT	245;245;242	A;G;T	229;229;226	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5762	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2965	193.8	1	SNP	p	S88P	0	.	.	262	264	TCC	556	558	TCC	239;238;240	T;C;C	222;223;222	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4986	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2655	187.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1565	1567	GGC	268;267;264	G;G;C	244;239;236	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1234	1236	GCA	229;232;231	G;C,A;A	214;209,1;213	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1237	1239	ATC	234;233;235	A;T;C	217;215;215	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1249	1251	GTG	224;223;225	G;T;G	208;206;207	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1249	1251	GTG	224;223;225	G;T;G	208;206;207	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1753	1755	ACC	217;218;218	A;C;C	190;197;199	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1807	1809	GCG	228;229;227	G;C,G;G	198;184,1;188	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1807	1809	GCG	228;229;227	G;C,G;G	198;184,1;188	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1930	1932	GGC	171;168;168	G;G;C	155;154;156	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1939	1941	GGC	159;154;153	G;G;C	146;138;138	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4330	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2353	183.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1957	1959	CCG	138;142;141	C,G;C;G	104,3;110;107	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6226	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3165	196.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2530	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1767	142.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	588	588	C	202	C	187	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	475	477	GGA	254;256;260	G;G;A	242;243;247	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	0	.	p	.	0	F135L	NONSYN	403	405	TTT	736	738	CTT	239;237;236	C;T;T	222;219;219	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	0	.	p	.	0	R143G	NONSYN	427	429	AGA	760	762	GGA	238;236;232	G;G;A	223;220;216	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	0	.	p	.	0	D171G	NONSYN	511	513	GAT	844	846	GGT	239;239;243	G;G;T	225;226;226	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	0	.	p	.	0	G189S	NONSYN	565	567	GGC	898	900	AGC	231;229;229	A;G;C	216;215;214	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	964	964	T	199	T	189	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	1	SNP	p	G120K	0	.	.	358	360	GGT	691	693	GGT	247;247;247	G,T;G;T	231,1;232;229	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	1	SNP	p	A121D	0	.	.	361	363	GCC	694	696	GCC	246;246;249	G;C;C	230;232;234	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2980	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1531	193.9	1	SNP	p	A121N	0	.	.	361	363	GCC	694	696	GCC	246;246;249	G;C;C	230;232;234	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11638	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4731	245.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1937	1939	AAT	251;248;247	A;A;T	233;230;227	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1266	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	978	128.6	1	SNP	p	V57M	1	.	.	169	171	ATG	465	467	ATG	257;259;261	A;T;G	240;240;240	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
